Description
IGF::OT::IGF COST/TEST CONTRACT FOR MICROBIOLOGY STUDIES/TESTING. THE FOLLOWING IS THE EQUIPMENT AND SUPPLIES DISCRIPTION: 1 EA, B1018-396, WALKAWAY-96 PLUS SYSTEM, 1 EA, B1018-340, WALKAWAY-40 PLUS, SYSTEM, WHICH INCLUDES: [(7) 60 ML REAGENTS BOTTLE, (3) 30 ML REAGENTS BOTTLE, LABPRO VERSION 3.0 WITH ALERT EX UPS], 1 EA, B1018-14, RENOK, 1 EA, B1018-66, TURBIDITY METER, 1 EA, B1018-516, LABPRO ALERT-EX
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-09+$59,515= $59,515
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-09 | +$59,515 | $59,515 | IGF::OT::IGF COST/TEST CONTRACT FOR MICROBIOLOGY STUDIES/TESTING. THE FOLLOWING IS THE EQUIPMENT AND SUPPLIES… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under W065 from 248-NETWORK CONTRACT OFFICE 8 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24816F07831 | GETINGE USA INC | 248-NETWORK CONTRACT OFFICE 8 | $288 | FY2016 |
| VA24816F0822 | SIZEWISE RENTALS, L.L.C. | 248-NETWORK CONTRACT OFFICE 8 | $288 | FY2016 |
| VA24816P0747 | PRI MEDICAL TECHNOLOGIES INC. | 248-NETWORK CONTRACT OFFICE 8 | $5,500 | FY2016 |
| VA24816P0115 | KREG THERAPEUTICS LLC | 248-NETWORK CONTRACT OFFICE 8 | $24,478 | FY2016 |
| VA24815P1494 | DURA MEDICAL EQUIPMENT INC | 248-NETWORK CONTRACT OFFICE 8 | $328,957 | FY2015 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24816F0060_3600_V797P7090A_3600 · retrieved 2026-09-26.